Not checked for notices yet.

Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway

Ji-Yeon Lee, Minyoung Lee, Ji Young Lee and 6 more (opens in a new tab)

Diabetes & Metabolism Journal · 2021

doi:10.4093/dmj.2020.0187 (opens in a new tab)

Cited by papers we hold 1

Ketone bodies: from enemy to friend and guardian angel · 2021
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.